Literature DB >> 26165796

Tunable Riboregulator Switches for Post-transcriptional Control of Gene Expression.

Malathy Krishnamurthy1, Scott P Hennelly1, Taraka Dale1, Shawn R Starkenburg1, Ricardo Martí-Arbona1, David T Fox1, Scott N Twary1, Karissa Y Sanbonmatsu1, Clifford J Unkefer1.   

Abstract

Until recently, engineering strategies for altering gene expression have focused on transcription control using strong inducible promoters or one of several methods to knock down wasteful genes. Recently, synthetic riboregulators have been developed for translational regulation of gene expression. Here, we report a new modular synthetic riboregulator class that has the potential to finely tune protein expression and independently control the concentration of each enzyme in an engineered metabolic pathway. This development is important because the most straightforward approach to altering the flux through a particular metabolic step is to increase or decrease the concentration of the enzyme. Our design includes a cis-repressor at the 5' end of the mRNA that forms a stem-loop helix, occluding the ribosomal binding sequence and blocking translation. A trans-expressed activating-RNA frees the ribosomal-binding sequence, which turns on translation. The overall architecture of the riboregulators is designed using Watson-Crick base-pairing stability. We describe here a cis-repressor that can completely shut off translation of antibiotic-resistance reporters and a trans-activator that restores translation. We have established that it is possible to use these riboregulators to achieve translational control of gene expression over a wide dynamic range. We have also found that a targeting sequence can be modified to develop riboregulators that can, in principle, independently regulate translation of many genes. In a selection experiment, we demonstrated that by subtly altering the sequence of the trans-activator it is possible to alter the ratio of the repressed and activated states and to achieve intermediate translational control.

Entities:  

Keywords:  gene expression; pathway engineering; riboregulators; synthetic biology; translational control

Mesh:

Substances:

Year:  2015        PMID: 26165796      PMCID: PMC6849397          DOI: 10.1021/acssynbio.5b00041

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  37 in total

1.  Improving lycopene production in Escherichia coli by engineering metabolic control.

Authors:  W R Farmer; J C Liao
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

2.  Engineered riboregulators enable post-transcriptional control of gene expression.

Authors:  Farren J Isaacs; Daniel J Dwyer; Chunming Ding; Dmitri D Pervouchine; Charles R Cantor; James J Collins
Journal:  Nat Biotechnol       Date:  2004-06-20       Impact factor: 54.908

3.  Pathway engineering via quorum sensing and sRNA riboregulators-interconnected networks and controllers.

Authors:  Karen K Carter; James J Valdes; William E Bentley
Journal:  Metab Eng       Date:  2011-12-07       Impact factor: 9.783

Review 4.  Synthetic biology and the development of tools for metabolic engineering.

Authors:  Jay D Keasling
Journal:  Metab Eng       Date:  2012-02-01       Impact factor: 9.783

Review 5.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Authors:  Regina Stoltenburg; Christine Reinemann; Beate Strehlitz
Journal:  Biomol Eng       Date:  2007-06-16

6.  Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly.

Authors:  Farnaz F Nowroozi; Edward E K Baidoo; Simon Ermakov; Alyssa M Redding-Johanson; Tanveer S Batth; Christopher J Petzold; Jay D Keasling
Journal:  Appl Microbiol Biotechnol       Date:  2013-11-21       Impact factor: 4.813

7.  Genetic switchboard for synthetic biology applications.

Authors:  Jarred M Callura; Charles R Cantor; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-27       Impact factor: 11.205

8.  Co-variation of tRNA abundance and codon usage in Escherichia coli at different growth rates.

Authors:  H Dong; L Nilsson; C G Kurland
Journal:  J Mol Biol       Date:  1996-08-02       Impact factor: 5.469

Review 9.  RNA aptamer evolution: two decades of SELEction.

Authors:  Guillermo Aquino-Jarquin; Julia D Toscano-Garibay
Journal:  Int J Mol Sci       Date:  2011-12-08       Impact factor: 5.923

10.  Dissecting engineered cell types and enhancing cell fate conversion via CellNet.

Authors:  Samantha A Morris; Patrick Cahan; Hu Li; Anna M Zhao; Adrianna K San Roman; Ramesh A Shivdasani; James J Collins; George Q Daley
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

View more
  5 in total

1.  Building an RNA-Based Toggle Switch Using Inhibitory RNA Aptamers.

Authors:  Alicia Climent-Catala; Thomas E Ouldridge; Guy-Bart V Stan; Wooli Bae
Journal:  ACS Synth Biol       Date:  2022-02-08       Impact factor: 5.110

2.  An in vivo selection system with tightly regulated gene expression enables directed evolution of highly efficient enzymes.

Authors:  Parinthon Nearmnala; Manutsawee Thanaburakorn; Watanalai Panbangred; Pimchai Chaiyen; Narupat Hongdilokkul
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 3.  Bacterial genome engineering and synthetic biology: combating pathogens.

Authors:  Malathy Krishnamurthy; Richard T Moore; Sathish Rajamani; Rekha G Panchal
Journal:  BMC Microbiol       Date:  2016-11-04       Impact factor: 3.605

4.  Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.

Authors:  Chengle Zhuang; Xinbo Huang; Changshui Zhuang; Xiaomin Luo; Xiaowei Zhang; Zhiming Cai; Yaoting Gui
Journal:  J Exp Clin Cancer Res       Date:  2017-10-30

5.  Allosteric DNA nanoswitches for controlled release of a molecular cargo triggered by biological inputs.

Authors:  Marianna Rossetti; Simona Ranallo; Andrea Idili; Giuseppe Palleschi; Alessandro Porchetta; Francesco Ricci
Journal:  Chem Sci       Date:  2016-11-03       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.